自动化药监证据生成:使用大型语言模型来产生情境感知结构化查询语言
Jeffery L Painter1, Venkateswara Rao Chalamalasetti1,2, Raymond Kassekert3
1GlaxoSmithKline, Durham, NC 27701, United States.
JAMIA open
|February 10, 2025
概括
大型语言模型 (LLM) 现在可以将自然语言查询转换为用于药监数据库的SQL. 添加业务背景显著提高了准确度,从8.3%提高到78.3%.
科学领域:
- 药物监督 药物监督 药物监督
- 人工智能的人工智能
- 数据库管理数据库管理
背景情况:
- 药监数据库需要复杂的查询来检索安全数据.
- 自然语言查询 (NLQ) 往往难以转换为结构化查询语言 (SQL),用于数据库交互.
- 大型语言模型 (LLM) 提供了自动化NLQ到SQL转换的潜力.
研究的目的:
- 提高药监数据库中信息检索准确度.
- 开发一种使用LLMs将NLQ转换为SQL查询的方法.
- 评估业务环境对LLM驱动查询生成的影响.
主要方法:
- 在检索增强生成 (RAG) 框架内利用了OpenAI的GPT-4模型.
- 通过商业背景文件丰富了RAG框架.
- 评估了在不同的查询复杂度 (低,中,高) 的LLM绩效,无论在业务环境中还是没有.
主要成果:
- 从NLQ到SQL的准确性从8.3% (仅用于图表) 增加到78.3%,使用商业背景文档.
- 在所有查询复杂度级别中,准确度的改进是一致的.
- 除了高度复杂的查询外,性能达到高达85%,表明部署的巨大潜力.
结论:
- 整合业务环境显著提高了LLM准确性,用于生成可执行和语义上正确的SQL查询.
- 拟议的方法提高了非技术用户对药监数据的可访问性.
- 这种方法为改善各种数据密集型领域的数据检索提供了可转移的框架.
相关概念视频
Pharmacovigilance
769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
Structure-Activity Relationships and Drug Design
491
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
491
Pharmacokinetic Models: Overview
558
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
558
Analysis of Population Pharmacokinetic Data
218
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
218
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K


